Current NDC auxiliary source row compounder:3203

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 83298-400
Product Ndc: 83298-400
Product Ndc Digits: 83298400
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Phenylephrine Hydrochloride
Proprietary Name Suffix: [empty]
Nonproprietary Name: Phenylephrine Hydrochloride
Dosage Form Name: INJECTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Mark Cuban Cost Plus Manufacturing and Compounding LLC
Establishment Name: Mark Cuban Cost Plus Manufacturing and Compounding LLC
Establishment Fei: [empty]
Substance Name: PHENYLEPHRINE HYDROCHLORIDE
Active Ingredients Info: 1 mg/10 mL
History Active Ingredients Raw: PHENYLEPHRINE HYDROCHLORIDE
History Active Ingredients Info Raw: 1 mg/10 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 83298-400-05
Package Ndc: 83298-400-05
Package Ndc Digits: 8329840005
Package Ndc11: 83298040005
Package Description: 5 SYRINGE in 1 POUCH (83298-400-05) > 10 mL in 1 SYRINGE (83298-400-19)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:3203
Source Row Number: 3203
Source Row Hash: 2c6105608e3e24c6cfdb4ab49890e299b974f52bc5c7af82502d20dd15c80df0
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "83298-400",
    "DEASCHEDULE": "",
    "LABELERNAME": "Mark Cuban Cost Plus Manufacturing and Compounding LLC",
    "SUBSTANCENAME": "PHENYLEPHRINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "83298-400-05",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Phenylephrine Hydrochloride",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Phenylephrine Hydrochloride",
    "PACKAGEDESCRIPTION": "5 SYRINGE in 1 POUCH (83298-400-05)  > 10 mL in 1 SYRINGE (83298-400-19) ",
    "ACTIVEINGREDIENTSINFO": "1 mg/10 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:3203
Source Row Number: 3203
Status Scope: package
Lookup Ndc: 83298-400-05
Lookup Ndc Digits: 8329840005
Product Ndc: 83298-400
Product Ndc Digits: 83298400
Package Ndc: 83298-400-05
Package Ndc Digits: 8329840005
Package Ndc11: 83298040005
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 2c6105608e3e24c6cfdb4ab49890e299b974f52bc5c7af82502d20dd15c80df0
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01